Company Overview of Progen Pharmaceuticals, Inc.
Progen Pharmaceuticals, Inc. discovers and develops small molecule pharmaceuticals for the treatment of anti-proliferation and cancer therapeutics. The company’s products are also used for the treatment of various diseases, including age-related macular degeneration, infectious diseases, inflammatory diseases, and vascular hyperplasia. Progen Pharmaceuticals, Inc. was formerly known as CellGate, Inc. and changed its name to Progen Pharmaceuticals, Inc. in February, 2008. The company was founded in 1998 and is based in Palo Alto, California. Progen Pharmaceuticals, Inc. operates as a subsidiary of TBG Diagnostics Limited.
2479 East Bayshore Road
Palo Alto, CA 94303
Founded in 1998
Key Executives for Progen Pharmaceuticals, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Progen Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.